AZ boosts training with simulations

Share this article:
AstraZeneca has been using sales simulations to help bolster rep training for real product details behind its new asthma drug Symbicort.

“We are big believers in the use of simulations in sales training,” AstraZeneca's Mark Mallon told MM&M during a recent interview. “In addition to traditional product and disease training, we use role plays to create customers that have profiles. The representatives then call on them multiple times in the training.”

Mallon said the Symbicort training program proved to be highly effective. “Literally 10 minutes within arriving at the launch meeting, reps were detailing real physicians. We think that's very powerful.”

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...